Anti-cancer combinations
US7462642B2 · kind B2 · utility
109Cited by
14References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2004 |
| Grant date | Dec 9, 2008 |
| Priority date | — |
| Expiry date | Sep 15, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to synergistic combinations of the compounds of formula I such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and NSAIDs, in particular diclofenac, which have anti-tumor activity. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing said combinations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.